Inotuzumab ozogamicin in individuals with Down syndrome and acute lymphoblastic leukemia.

Li AM, Aftandilian C, Annesley C, Colace S, Faulk KE, Goldman JW, Guest E, Hayani A, Ho R, Jabbour E, Khanna-Farber A, Kyono W, Leger K, Maloney K, McCall D, Miller T, Pacenta HL, Quigg TC, Rubinstein JD, Schafer E, Rheingold SR, Bhojwani D, O'Brien MM, Rabin KR